149 related articles for article (PubMed ID: 12691468)
21. New therapeutic strategies for hepatitis C.
Di Bisceglie AM; McHutchison J; Rice CM
Hepatology; 2002 Jan; 35(1):224-31. PubMed ID: 11786980
[No Abstract] [Full Text] [Related]
22. Hepatitis C virus: prospects for future therapies.
Wilkinson T
Curr Opin Investig Drugs; 2001 Nov; 2(11):1516-22. PubMed ID: 11763151
[TBL] [Abstract][Full Text] [Related]
23. New therapies on the horizon for hepatitis C.
Sookoian SC
Ann Hepatol; 2003; 2(4):164-70. PubMed ID: 15115955
[TBL] [Abstract][Full Text] [Related]
24. Hepatitis C virus virology and new treatment targets.
Meier V; Ramadori G
Expert Rev Anti Infect Ther; 2009 Apr; 7(3):329-50. PubMed ID: 19344246
[TBL] [Abstract][Full Text] [Related]
25. New drug targets for HIV and hepatitis C virus coinfection.
Tedaldi EM
Clin Infect Dis; 2005 Jul; 41 Suppl 1():S101-4. PubMed ID: 16265606
[TBL] [Abstract][Full Text] [Related]
26. Advances in the treatment of hepatitis B virus/hepatitis C virus coinfection.
Sagnelli E; Pisaturo M; Martini S; Sagnelli C; Filippini P; Coppola N
Expert Opin Pharmacother; 2014 Jul; 15(10):1337-49. PubMed ID: 24773464
[TBL] [Abstract][Full Text] [Related]
27. Understanding the molecular targets for new therapeutical agents in hepatitis c infection.
Vagu C; Sultana C; Ruţă S
Roum Arch Microbiol Immunol; 2013; 72(1):5-24. PubMed ID: 23947011
[TBL] [Abstract][Full Text] [Related]
28. Liver-specific mono-unsaturated fatty acid synthase-1 inhibitor for anti-hepatitis C treatment.
Nio Y; Hasegawa H; Okamura H; Miyayama Y; Akahori Y; Hijikata M
Antiviral Res; 2016 Aug; 132():262-7. PubMed ID: 27392483
[TBL] [Abstract][Full Text] [Related]
29. Pathogenesis, diagnosis and management of hepatitis C.
Boyer N; Marcellin P
J Hepatol; 2000; 32(1 Suppl):98-112. PubMed ID: 10728798
[TBL] [Abstract][Full Text] [Related]
30. Hepatitis C virus dynamics in vivo: effect of ribavirin and interferon alfa on viral turnover.
Zeuzem S; Schmidt JM; Lee JH; von Wagner M; Teuber G; Roth WK
Hepatology; 1998 Jul; 28(1):245-52. PubMed ID: 9657119
[TBL] [Abstract][Full Text] [Related]
31. Current and future concepts in hepatitis C therapy.
Pawlotsky JM
Semin Liver Dis; 2005 Feb; 25(1):72-83. PubMed ID: 15731999
[TBL] [Abstract][Full Text] [Related]
32. Novel therapies for hepatitis C virus based on lessons from virology.
Glenn JS
Clin Gastroenterol Hepatol; 2005 Oct; 3(10 Suppl 2):S86-8. PubMed ID: 16234068
[TBL] [Abstract][Full Text] [Related]
33. Hepatitis C viral kinetics in plasma and peripheral blood mononuclear cells during pegylated interferon-alpha2a/ribavirin therapy.
Pugnale P; Herrmann E; Neumann AU; Pawlotsky JM; Schalm SW; Ferrari C; Homburger Y; Zeuzem S; Negro F;
J Hepatol; 2008 Jun; 48(6):932-8. PubMed ID: 18433918
[TBL] [Abstract][Full Text] [Related]
34. [New possibilities on the horizon for the treatment of hepatitis C virus infection: direct-acting antiviral therapy].
Pár A
Orv Hetil; 2010 Dec; 151(50):2045-56. PubMed ID: 21126947
[TBL] [Abstract][Full Text] [Related]
35. New perspectives in HCV therapy: entry inhibitors.
Donia M; Cacopardo B; Libra M; Scalia G; McCubrey JA; Nicoletti F
Recent Pat Antiinfect Drug Discov; 2010 Nov; 5(3):181-94. PubMed ID: 20497122
[TBL] [Abstract][Full Text] [Related]
36. Inhibitory effects of Pycnogenol® on hepatitis C virus replication.
Ezzikouri S; Nishimura T; Kohara M; Benjelloun S; Kino Y; Inoue K; Matsumori A; Tsukiyama-Kohara K
Antiviral Res; 2015 Jan; 113():93-102. PubMed ID: 25446333
[TBL] [Abstract][Full Text] [Related]
37. Approaches to the development of novel inhibitors of hepatitis C virus replication.
Clarke BE
J Viral Hepat; 1995; 2(1):1-8. PubMed ID: 7493290
[TBL] [Abstract][Full Text] [Related]
38. Hepatitis C virus: current understanding and prospects for future therapies.
Rosen HR; Gretch DR
Mol Med Today; 1999 Sep; 5(9):393-9. PubMed ID: 10462751
[TBL] [Abstract][Full Text] [Related]
39. An NS3 protease inhibitor with antiviral effects in humans infected with hepatitis C virus.
Lamarre D; Anderson PC; Bailey M; Beaulieu P; Bolger G; Bonneau P; Bös M; Cameron DR; Cartier M; Cordingley MG; Faucher AM; Goudreau N; Kawai SH; Kukolj G; Lagacé L; LaPlante SR; Narjes H; Poupart MA; Rancourt J; Sentjens RE; St George R; Simoneau B; Steinmann G; Thibeault D; Tsantrizos YS; Weldon SM; Yong CL; Llinàs-Brunet M
Nature; 2003 Nov; 426(6963):186-9. PubMed ID: 14578911
[TBL] [Abstract][Full Text] [Related]
40. Strategies for hepatitis C therapeutic intervention: now and next.
Tan SL; He Y; Huang Y; Gale M
Curr Opin Pharmacol; 2004 Oct; 4(5):465-70. PubMed ID: 15351350
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
